Join
Live feed
·
INSIDERFilingvia Quantisnow
Spero Therapeutics Inc. logo

CEO & President Shukla Sath was granted 751,407 shares and sold $121,160 worth of shares (155,333 units at $0.78), increasing direct ownership by 52% to 1,736,883 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.